DexCom Opens Data Platform and Launches Developer Program to Fuel Diabetes App Innovation
September 19 2017 - 08:00AM
Business Wire
CGM Leader Introduces Public Application
Programming Interface (API)
DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose
monitoring (CGM), announced today the availability of a public API,
empowering third-party developers to connect patient-authorized CGM
data into a broad range of software applications. This pioneering
approach to CGM data sharing is intended to enable a rich ecosystem
of novel solutions and put the user in control of where and how
they interact with their glucose data.
“In launching this developer platform, Dexcom combines our CGM
data expertise with the creativity of the developer ecosystem to
enable new solutions and business models in the treatment and
management of diabetes,” said Annika Jimenez, Senior Vice President
of Data, Dexcom. “Dexcom believes in data mobility and customer
choice. It also believes that the API opens up opportunities to
drive Dexcom CGM data into the heart of new digital solutions for
payers, providers, and most importantly people with diabetes.”
Continuous glucose monitoring allows people with diabetes to
continuously track their blood glucose levels in real-time. Dexcom
CGM systems provide dynamic glucose information every five minutes,
which creates a continuous stream of glucose data that can be
invaluable for individual and population diabetes management. The
Dexcom API allows Dexcom to ensure CGM data collaboration is
secure, patient-privacy-centric, and FDA-compliant, while
supporting a broad variety of new solutions and business
models.
"Diabetes is a data-driven disease," said Jeff Dachis, Founder
and Chief Executive Officer of One Drop, a leading digital diabetes
management solution and Dexcom API user. “By combining Dexcom data
with One Drop’s ability to connect users, coaches and diabetes
peers, this partnership will help drive innovation and will bring
about more affordable, accessible, scalable, and effective
solutions. It's a big win for people with diabetes.”
As of today, developers in the US can register at
https://developer.dexcom.com and immediately access the Dexcom API.
Several well-established companies and startups in the diabetes
space including One Drop, Nutrino, Tidepool, Rimidi, Evidation,
Ensa, and App Practice are already accessing the API for
patient-approved CGM data retrieval.
“AppPractice’s new platform allows clinicians to view
their patient’s glucose on the same day via their
smartphones, as part of their mHealth patient care practice,” said
Dr. Rakesh Patel, Endocrinologist, entrepreneur and founder of App
Practice. “By using the data from the Dexcom API, our clinicians
can now make timely changes and adjust insulin for their
patients more effectively. Access to patient data like this
enables clinicians to dramatically improve patient care and
can lower healthcare costs.”
Dexcom customers will benefit from the apps these companies have
developed in many ways; for example:
- Clinicians can now view their diabetes
patients’ glucose data on their smartphones, as part of their
mobile practice patient care and billing workflows.
- Patients are able to receive automated,
personalized insights gained from combining data from their
diabetes devices, medical records, and other apps and
wearables.
- Dexcom users can explore how their food
choices impact their glucose control and connect with and learn
from coaches and diabetes peers in a data-driven community.
“Dexcom has always been a pioneer in diabetes technology,” said
Kevin Sayer, President and CEO, Dexcom. “Now we are extending our
thought leadership into the data our device generates by enabling
broad collaboration with digital health partners.”
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, CA, is dedicated
to helping people better manage their diabetes by developing and
marketing continuous glucose monitoring (CGM) products and tools
for adult and pediatric patients. With exceptional performance,
patient comfort and lifestyle flexibility at the heart of its
technology, users have consistently ranked DexCom highest in
customer satisfaction and loyalty. For more information, visit
www.dexcom.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170919005708/en/
DexCom, Inc.Media ContactJames
McIntosh, 619-884-2118jmcintosh@allisonpr.comorInvestor ContactSteven Pacelli,
858-200-0200spacelli@dexcom.com
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Feb 2024 to Mar 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Mar 2023 to Mar 2024